National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 57500 [2022-20281]
Download as PDF
<![CDATA[
57500
Federal Register / Vol. 87, No. 181 / Tuesday, September 20, 2022 / Notices
Open: 9:45 a.m. to 11:30 a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institutes of Health,
National Institute on Aging, Biomedical
Research Center, 251 Bayview Boulevard,
Baltimore, MD 21224 (Virtual Meeting).
Closed: 11:30 a.m. to 1 p.m.
Agenda: Executive Session.
Place: National Institutes of Health,
National Institute on Aging, Biomedical
Research Center, 251 Bayview Boulevard,
Baltimore, MD 21224 (Virtual Meeting).
Contact Person: Luigi Ferrucci, Ph.D., MD,
Scientific Director, National Institute on
Aging, 251 Bayview Boulevard, Suite 100,
Room 4C225, Baltimore, MD 21224, 410–
558–8110, LF27Z@NIH.GOV.
Information is also available on the
Institute’s/Center’s home page:
www.nia.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS.)
Dated: September 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Songtao Liu, MD,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, MSC 5469,
Bethesda, MD 20817, (301) 827–3025,
songtao.liu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: September 15, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20286 Filed 9–19–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
H–SEP.
Date: October 26–27, 2022.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:48 Sep 19, 2022
Jkt 256001
Dated: September 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20281 Filed 9–19–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
[FR Doc. 2022–20282 Filed 9–19–22; 8:45 am]
BILLING CODE 4140–01–P
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS.)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Study Section.
Date: October 26–28, 2022.
Time: 10 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Suite 7017, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Charlene J. Repique, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7347, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7791,
charlene.repique@nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/, where an agenda and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Eye
Council.
The meeting will be held as a virtual
meeting on October 14, 2022 and is
open to the public as indicated below.
The open session (event) will be
videocast by NIH with closed captioning
at: https://videocast.nih.gov/
watch=46066. To request reasonable
accommodations, please contact
Nathan.Brown2@nih.gov at least five
days before the event. The agenda can
be found at: https://www.nei.nih.gov/
about/advisory-committees/nationaladvisory-eye-council-naec/nationaladvisory-eye-council-naec-meetingagenda.
A portion of this meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: October 14, 2022.
Open: 10 a.m. to 2:30 p.m.
Agenda: Presentation of the NEI Director’s
report and discussion of NEI programs.
Place: National Eye Institute, National
Institutes of Health, 6700 Rockledge Drive,
Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Closed: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 87, Number 181 (Tuesday, September 20, 2022)]
[Notices]
[Page 57500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20281]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Diabetes, Endocrinology
and Metabolic Diseases B Study Section.
Date: October 26-28, 2022.
Time: 10 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd.,
Suite 7017, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Charlene J. Repique, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7347, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-7791, [email protected].
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS.)
Dated: September 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20281 Filed 9-19-22; 8:45 am]
BILLING CODE 4140-01-P
